What's New

Press Releases

AnaptysBio announces collaboration with VLST to generate novel antibody therapeutics (140 KB PDF)
April 5, 2010

VLST Corporation and Novo Nordisk announce collaboration agreement to develop therapeutics for autoimmune and inflammatory disorders (22 KB PDF)
December 17, 2008

VLST Corporation Appoints Internationally Recognized Researcher Paul J. Carter, Ph.D. as Chief Scientific Officer (22 KB PDF)
July 2, 2008

VLST Corporation Announces Board and Executive Management Appointments (23 KB PDF)
February 13, 2008

VLST Corp Names Consuelo M. Blosch, M.D., Vice President of Clinical and Regulatory and Dan Allison, Ph.D., Sr. Director of Therapeutic Design (58 KB PDF)
September 12, 2007

VLST Corp. Raises $55 Million: First Accelerator Company to Complete Series B Financing (15 KB PDF)
June 16, 2006

VLST Corp. Names Julie M. Eastland as Chief Financial Officer (76 KB PDF)
March 3, 2006

VLST Corp & Accelerator Corporation Name Martin A. Simonetti President and Chief Executive Officer of VLST (80 KB PDF)
January 5, 2006

Accelerator Corporation Adds $11.8 Million and Two New Investors (12 KB PDF)
November 18, 2004

Accelerator Corporation Funds Two Emerging Biotech Companies (16 KB PDF)
March 19, 2004